Adamed - Partner of Polish Cardiology 2012

About Adamed
About Adamed
Adamed in Poland
Adamed across the globe
Management Team of Adamed Pharma S.A.
Mission and values
Ethics and Compliance
Adamed for the Family
News
Adamed is a pharmaceutical and biotechnology company with almost 40 years of experience, founded on the basis of Polish scientific advances and a patent portfolio.
Products
Produkty
Prescription drugs
OTC drugs
Dietary supplements
Dermocosmetics
Medical devices
We provide patients with the highest quality medicinal products that are a response to chronic civilization diseases in several therapeutic areas.
Development and innovation
Development and innovation
Research
Development of proprietary medicines
Development of value-added medicines
Business development Startups Requests for proposals and tenders
Innovation is at the core of Adamed’s evolution. It allows us to pursue our mission by responding to the key challenges of modern medicine.
ESG
CSR
Adamed Foundation
Social programmes
Code of Ethics
Responsibility is one of our key values. It is at the core of everything we do and has earned us the trust of patients and the medical community.
Career
Career
Benefits
Development
Locations
Internships and apprenticeships
People are a priority at Adamed, and their passion and dedication has helped us grow into a successful company. Recognising the value of our staff, we are committed to providing excellent work conditions and career opportunities.
Contact

Global English

Popular searches Innovations About Adamed Business Development Adamed worldwide Researches

x

Events

28 September 2012

Małgorzata Adamkiewicz, CEO, Adamed Group: Awarding the title of Partner of Polish Cardiology once again to Adamed is a great honor for us, and at the same time it recognizes our daily work for the protection of health and life of Polish patients. Research and development are pillars on which the operations of our company stand on. We are seeking innovative therapies in various therapeutic groups, including cardiology.

During the Congress, the Adamed Group awarded two, young scientists the 2012 ADAMED Research Grant totaling 50 000 PLN. Its recipients are Dr. Eliza Kozyra-Pydyś, M.D., and Dr. Marcin Grabowski, Ph.D., M.D. for their study: Monitoring hemostatic markers of endothelial dysfunctions and thromboembolic complications in patients with heart stimulants. The grant was awarded by Grzegorz Michniewski, President of the Board, Adamed Sp. z o o.o., who congratulated the scientists on their work and wished them success in their project.